Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Suzanne Rogers RN, Newport Beach's Expert Aesthetic Nurse Injector Explains The Difference Between Today’s Top Injectables
  • USA - English


News provided by

Gallery of Cosmetic Surgery

Mar 15, 2016, 13:50 ET

Share this article

Share toX

Share this article

Share toX

Suzanne Rogers RN, Certified National Trainer and Orange County's Expert Level Aesthetic Nurse Injector
Suzanne Rogers RN, Certified National Trainer and Orange County's Expert Level Aesthetic Nurse Injector

Fillers are subdivided into hyaluronic acid (including Juvederm and Restylane), calcium hydroxyapatite (including Radiesse), and poly L-lactic acid (including Sculptra), each offering its own advantages depending on the patient’s individualized needs.

Post this

Newport Beach, CA (PRWEB) March 15, 2016 -- Suzanne Rogers is a Certified National Trainer and considered one of Orange County’s expert level aesthetic nurse injectors. Working at the Gallery of Cosmetic Surgery, Suzanne is able to provide patients with the youthful, natural-looking results they desire. She has the ability to individualize each patient’s treatment, ensuring she uses the most effective rejuvenation products including Perlane, Juvederm, Voluma, Restylane, Sculptra and much more. At the Gallery of Cosmetic Surgery, she is able to help a wide range of patients improve their appearance non-surgically or add finishing touches post-surgery. Along with helping patients find the right injectable to suit their needs, Suzanne trains Board Certified Dermatologists, Plastic Surgeons and other highly qualified peers in the proper use of injectable treatments and techniques.

Recently, Suzanne explained the differences between the many injectable filler options offered at the Gallery of Cosmetic Surgery. “With a large number of filler options available, it can be overwhelming trying to find the right one for your needs,” Suzanne Rogers explains. “It is important to note that there is not one magical filler. Instead, fillers are subdivided into hyaluronic acid (including Juvederm and Restylane), calcium hydroxyapatite (including Radiesse), and poly L-lactic acid (including Sculptra), each offering its own advantages depending on the patient’s individualized needs.”

Suzanne notes that hyaluronic acid (HA) fillers are made of a molecule that is naturally found in the human body. Because it can be injected almost anywhere and can be easily reversible, it is a great option for first-time users. She explains that Juvederm is an example of this type of hyaluronic acid filler, but even it is subdivided into categories. Juvederm Ultra XC, for example, is injected higher in the dermis while Juvederm Ultra Plus XC in injected deeper. Both versions are very effective at reducing the look of wrinkles and folds. However, clinical studies found that Juvederm Ultra Plus held up a little better over time. Juvederm Voluma XC, another version, is designed to add volume beneath the skin’s surface, lifting and contouring the cheek area specifically, giving a more youthful appearance. It is injected deep in the cheek area.

Like Juvederm, Restylane is found in the hyaluronic acid family and can be subdivided into different versions: Perlane, Restylane Lyft and Restylane Silk. Restylane Lyft, for example, is specifically used for severe facial wrinkles and folds, while Silk is specifically geared towards plumping lips and reducing wrinkles around the mouth with a natural look. Sculptra, which is found in the poly L-lactic acid category, is considered a “collagen stimulator” which works gradually over a series of treatments. It helps repair the underlying skin structure with natural-looking results.

Suzanne Rogers, RN at the Gallery of Cosmetic Surgery offers a wide range of injectable fillers to help patients easily achieve a younger look without surgery. Some of the items offered include Juvederm Ultra XC, Juvederm Ultra Plus XC, Perlane, Restylane, Restylane Lyft, Restylane Silk, RADIESSE, Sculptra, KYBELLA,BOTOX, DYSPORT and more. If you are interested in what Dr. Kevin Sadati, Suzanne Rogers and the Gallery of Cosmetic Surgery can do for you, Call 949-706-7776 or visit the site at http://www.drkevinsadati.com.

Kristin Lohrer, Gallery of Cosmetic Surgery, http://www.galleryofcosmeticsurgery.com/, +1 9497067776, [email protected]

Modal title

Restylane Silk
Restylane Silk
Voted Best of OC by the Orange County Register
Voted Best of OC by the Orange County Register
Restylane Silk Voted Best of OC by the Orange County Register

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.